IL97578A0 - Plasmodium sporozoite antigen,dna coding therefor,use of said dna for its production and antibodies against it - Google Patents

Plasmodium sporozoite antigen,dna coding therefor,use of said dna for its production and antibodies against it

Info

Publication number
IL97578A0
IL97578A0 IL97578A IL9757891A IL97578A0 IL 97578 A0 IL97578 A0 IL 97578A0 IL 97578 A IL97578 A IL 97578A IL 9757891 A IL9757891 A IL 9757891A IL 97578 A0 IL97578 A0 IL 97578A0
Authority
IL
Israel
Prior art keywords
dna
production
antibodies against
coding therefor
sporozoite antigen
Prior art date
Application number
IL97578A
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL97578A0 publication Critical patent/IL97578A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205Plasmodium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/35Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL97578A 1990-03-23 1991-03-18 Plasmodium sporozoite antigen,dna coding therefor,use of said dna for its production and antibodies against it IL97578A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH97090 1990-03-23

Publications (1)

Publication Number Publication Date
IL97578A0 true IL97578A0 (en) 1992-06-21

Family

ID=4199439

Family Applications (1)

Application Number Title Priority Date Filing Date
IL97578A IL97578A0 (en) 1990-03-23 1991-03-18 Plasmodium sporozoite antigen,dna coding therefor,use of said dna for its production and antibodies against it

Country Status (9)

Country Link
EP (1) EP0447956A1 (en)
JP (1) JPH0686679A (en)
AU (1) AU637468B2 (en)
CA (1) CA2037151A1 (en)
IE (1) IE910966A1 (en)
IL (1) IL97578A0 (en)
NZ (1) NZ237447A (en)
PT (1) PT97117A (en)
ZA (1) ZA911950B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996007910A1 (en) * 1994-09-02 1996-03-14 Meiji Milk Products Company Limited Diagnostic drug for chlamydia infection
EP1221968B1 (en) * 1999-10-13 2010-01-13 Novartis Vaccines and Diagnostics, Inc. Method of obtaining cellular immune responses from proteins
RU2540871C2 (en) * 2008-02-01 2015-02-10 Альфа-О Пептидес Аг Self-assembling peptide nanoparticles effective as vaccines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ215023A (en) * 1985-02-07 1989-07-27 Smithkline Beckman Corp Vaccine against plasmodium falciparum and antigenic peptides
GB8615068D0 (en) * 1986-06-20 1986-07-23 Wellcome Found Vaccines
WO1988005817A1 (en) * 1987-01-30 1988-08-11 Smith Kline - Rit S.A. Expression of the p. falciparum circumsporozoite protein by yeast
AU625713B2 (en) * 1988-02-19 1992-07-16 Microgenesys, Inc. Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
FR2645877B1 (en) * 1989-04-12 1991-07-05 Pasteur Institut MOLECULES COMPRISING AT LEAST ONE PEPTIDE SEQUENCE CARRYING ONE, OR SEVERAL, CHARACTERISTIC EPITOPE OF A PROTEIN PRODUCED BY P. FALCIPARUM AT THE SPOROZOITE STAGE AND IN THE HEPATOCYTES
WO1991008756A1 (en) * 1989-12-12 1991-06-27 Biomedical Research Institute Novel malarial sporozoite peptide antigens

Also Published As

Publication number Publication date
PT97117A (en) 1991-11-29
ZA911950B (en) 1991-11-27
EP0447956A1 (en) 1991-09-25
NZ237447A (en) 1993-05-26
AU637468B2 (en) 1993-05-27
CA2037151A1 (en) 1991-09-24
JPH0686679A (en) 1994-03-29
IE910966A1 (en) 1991-09-25
AU7358991A (en) 1991-10-03

Similar Documents

Publication Publication Date Title
SG48314A1 (en) Improved antibodies to plasmodium falciparum
HUT66753A (en) Novel antibodies and methods for their use
EP0572529A4 (en) Aptamer specific for biomolecules and method of making.
EP0245993A3 (en) Monoclonal antibodies against c5a and des-arg74-c5a, their production and use
EP0456727A4 (en) Monoclonal antibodies directed against vitronectin and fibronectin, and uses thereof
OA07721A (en) Malaria associated antigen and preparing process thereof.
IL97578A0 (en) Plasmodium sporozoite antigen,dna coding therefor,use of said dna for its production and antibodies against it
ZA879621B (en) Method for the determination of anti-p.falciparum sporozoite antibodies in human blood
ZA937451B (en) Human monoclonal anti-peptide antibody and dna encoding thereof
EP0485476A4 (en) Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
NZ220797A (en) Male specific antibody against male specific antigen and its production
GB8919064D0 (en) Plasmodium merozoite rhoptries antigen
EP0582450A3 (en) Anti-oxytocin receptor antibodies and methods for their production.
EP0217877A4 (en) Highly repetitive antigens of plasmodium falciparum.
ZA947564B (en) Production of antigens
EP0520436A3 (en) Monoclonal antibody, method of production thereof and use thereof
IL83231A0 (en) Small molecular weight antigen of plasmodium falciparum,antibodies directed thereto,purification and detection of said antigen
EP0446763A3 (en) Antigen for producing anti-idiotype antibody, anti-idiotype antibody and method for producing the anti-idiotype antibody
ZA945696B (en) Novel Eimeria antibodies and antigens and methods of using the same
GB8921227D0 (en) Antibodies and proteins
IL88558A0 (en) Rhoptry antigen of plasmodium falciparum
EP0425676A4 (en) Digitizing method
GB9102294D0 (en) Antigen of plasmodium falciparum
ZA921231B (en) A plasmodium falciparum blood-stage antigen,the preparation and use thereof
EP0460674A3 (en) Recombinant dna and process for the production of chimaeric antibodies